Cargando…

Investigating the role of interleukin-1 beta and glutamate in inflammatory bowel disease and epilepsy using discovery browsing

BACKGROUND: Structured electronic health records are a rich resource for identifying novel correlations, such as co-morbidities and adverse drug reactions. For drug development and better understanding of biomedical phenomena, such correlations need to be supported by viable hypotheses about the mec...

Descripción completa

Detalles Bibliográficos
Autores principales: Rindflesch, Thomas C., Blake, Catherine L., Cairelli, Michael J., Fiszman, Marcelo, Zeiss, Caroline J., Kilicoglu, Halil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307110/
https://www.ncbi.nlm.nih.gov/pubmed/30587224
http://dx.doi.org/10.1186/s13326-018-0192-y
_version_ 1783382930479906816
author Rindflesch, Thomas C.
Blake, Catherine L.
Cairelli, Michael J.
Fiszman, Marcelo
Zeiss, Caroline J.
Kilicoglu, Halil
author_facet Rindflesch, Thomas C.
Blake, Catherine L.
Cairelli, Michael J.
Fiszman, Marcelo
Zeiss, Caroline J.
Kilicoglu, Halil
author_sort Rindflesch, Thomas C.
collection PubMed
description BACKGROUND: Structured electronic health records are a rich resource for identifying novel correlations, such as co-morbidities and adverse drug reactions. For drug development and better understanding of biomedical phenomena, such correlations need to be supported by viable hypotheses about the mechanisms involved, which can then form the basis of experimental investigations. METHODS: In this study, we demonstrate the use of discovery browsing, a literature-based discovery method, to generate plausible hypotheses elucidating correlations identified from structured clinical data. The method is supported by Semantic MEDLINE web application, which pinpoints interesting concepts and relevant MEDLINE citations, which are used to build a coherent hypothesis. RESULTS: Discovery browsing revealed a plausible explanation for the correlation between epilepsy and inflammatory bowel disease that was found in an earlier population study. The generated hypothesis involves interleukin-1 beta (IL-1 beta) and glutamate, and suggests that IL-1 beta influence on glutamate levels is involved in the etiology of both epilepsy and inflammatory bowel disease. CONCLUSIONS: The approach presented in this paper can supplement population-based correlation studies by enabling the scientist to identify literature that may justify the novel patterns identified in such studies and can underpin basic biomedical research that can lead to improved treatments and better healthcare outcomes.
format Online
Article
Text
id pubmed-6307110
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63071102019-01-02 Investigating the role of interleukin-1 beta and glutamate in inflammatory bowel disease and epilepsy using discovery browsing Rindflesch, Thomas C. Blake, Catherine L. Cairelli, Michael J. Fiszman, Marcelo Zeiss, Caroline J. Kilicoglu, Halil J Biomed Semantics Research BACKGROUND: Structured electronic health records are a rich resource for identifying novel correlations, such as co-morbidities and adverse drug reactions. For drug development and better understanding of biomedical phenomena, such correlations need to be supported by viable hypotheses about the mechanisms involved, which can then form the basis of experimental investigations. METHODS: In this study, we demonstrate the use of discovery browsing, a literature-based discovery method, to generate plausible hypotheses elucidating correlations identified from structured clinical data. The method is supported by Semantic MEDLINE web application, which pinpoints interesting concepts and relevant MEDLINE citations, which are used to build a coherent hypothesis. RESULTS: Discovery browsing revealed a plausible explanation for the correlation between epilepsy and inflammatory bowel disease that was found in an earlier population study. The generated hypothesis involves interleukin-1 beta (IL-1 beta) and glutamate, and suggests that IL-1 beta influence on glutamate levels is involved in the etiology of both epilepsy and inflammatory bowel disease. CONCLUSIONS: The approach presented in this paper can supplement population-based correlation studies by enabling the scientist to identify literature that may justify the novel patterns identified in such studies and can underpin basic biomedical research that can lead to improved treatments and better healthcare outcomes. BioMed Central 2018-12-27 /pmc/articles/PMC6307110/ /pubmed/30587224 http://dx.doi.org/10.1186/s13326-018-0192-y Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Rindflesch, Thomas C.
Blake, Catherine L.
Cairelli, Michael J.
Fiszman, Marcelo
Zeiss, Caroline J.
Kilicoglu, Halil
Investigating the role of interleukin-1 beta and glutamate in inflammatory bowel disease and epilepsy using discovery browsing
title Investigating the role of interleukin-1 beta and glutamate in inflammatory bowel disease and epilepsy using discovery browsing
title_full Investigating the role of interleukin-1 beta and glutamate in inflammatory bowel disease and epilepsy using discovery browsing
title_fullStr Investigating the role of interleukin-1 beta and glutamate in inflammatory bowel disease and epilepsy using discovery browsing
title_full_unstemmed Investigating the role of interleukin-1 beta and glutamate in inflammatory bowel disease and epilepsy using discovery browsing
title_short Investigating the role of interleukin-1 beta and glutamate in inflammatory bowel disease and epilepsy using discovery browsing
title_sort investigating the role of interleukin-1 beta and glutamate in inflammatory bowel disease and epilepsy using discovery browsing
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307110/
https://www.ncbi.nlm.nih.gov/pubmed/30587224
http://dx.doi.org/10.1186/s13326-018-0192-y
work_keys_str_mv AT rindfleschthomasc investigatingtheroleofinterleukin1betaandglutamateininflammatoryboweldiseaseandepilepsyusingdiscoverybrowsing
AT blakecatherinel investigatingtheroleofinterleukin1betaandglutamateininflammatoryboweldiseaseandepilepsyusingdiscoverybrowsing
AT cairellimichaelj investigatingtheroleofinterleukin1betaandglutamateininflammatoryboweldiseaseandepilepsyusingdiscoverybrowsing
AT fiszmanmarcelo investigatingtheroleofinterleukin1betaandglutamateininflammatoryboweldiseaseandepilepsyusingdiscoverybrowsing
AT zeisscarolinej investigatingtheroleofinterleukin1betaandglutamateininflammatoryboweldiseaseandepilepsyusingdiscoverybrowsing
AT kilicogluhalil investigatingtheroleofinterleukin1betaandglutamateininflammatoryboweldiseaseandepilepsyusingdiscoverybrowsing